CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...

An announcement from Liquidia Technologies ( ($LQDA) ) is now available. On October 27, 2025, Liquidia Technologies entered into an exclusive ...

An organization that has been a staple in the community for more than 100 years had to furlough its employees amid funding delays. Luckily, the closure was ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agreement with funds managed by RTW ...

The capacity of the Marana detention center is 500 people. In 2017, when the population of the private prison was near ...

Key Features to Consider in the Best Nebulizer Machine in India - Have you ever bought a health device that ended up ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

As cooler temperatures and shifting air quality arrive, many families notice changes in their breathing. Dry air, allergens, ...